Advancis Pharmaceutical Reaches Agreement With FDA for Resubmission of Amoxicillin PULSYS NDA (RedNova)
GERMANTOWN, Md., Feb. 28 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that it has conducted a meeting with the U.S.

US FDA seeks more data for Novartis diabetes treatment (New Ratings)
LONDON, February 26 (newratings.com) The US Food & Drug Administration (FDA) has issued an approvable letter for Swiss drug giant Novartis AG s ( NOT.FSE ) Galvus drug for the treatment of type II diabetes, seeking additional data related to the drug.

Idenix loss widens (Boston Business Journal)
Idenix Pharmaceuticals Inc. ended its 2006 fiscal year with higher net losses and flat revenue as it launched its first FDA-approved product and pushed to expand its pipeline.